Akèy › Dyabèt Tip 2 › Texas › Houston
Etid klinik pou Dyabèt Tip 2 nan Houston, TX
31 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Ap rekrite
- Houston Methodist, Houston
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Ap rekriteFaz 2
- Cardiovascular Specialists of Willowbrook, Houston
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Ap rekriteFaz 3
- JCCT- Juno NW Houston, Houston
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Ap rekriteFaz 3
- Victorium Clinical Research, Houston
- Houston Research Institute, Houston
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Ap rekriteFaz 3
- Juno Research, LLC, Houston
- Biopharma Informatic, Inc. Research Center, Houston
- Research Physicians Network, Houston
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Ap rekriteVolontè an sante akeyi
- Helium Research Group, Houston
- Kelsey Research Foundation, Houston
- The Methodist Hospital, DeBakey Cardiology Associates, Houston
- ak 1 plis
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Ap rekriteFaz 3
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Houston
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Ap rekriteFaz 3
- Juno Research, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Ap rekriteFaz 3
- Research Site, Houston
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Houston
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Ap rekriteFaz 3
- HRI ? Medical Center, LLC, Houston
- Juno Research, LLC, Houston
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Ap rekriteFaz 2
- Juno Research, Houston
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Ap rekriteFaz 2
- JCCT- Juno NW Houston, Houston
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Ap rekriteFaz 2
- Juno Research, LLC, Houston
- Prolato Research LLC, Houston
- Clinical Trial Network, LLC, Houston
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Ap rekriteFaz 2
- Private Practice - Dr. Laila A. Hassan, Houston
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Ap rekriteFaz 2
- Juno Research, LLC, Houston
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Ap rekriteFaz 3
- Amir Ali Hassan, MD, PA, Houston
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Ap rekriteFaz 2
- Biopharma Informatic, LLC, Houston
- PlanIt Research, PLLC, Houston
- Research Physicians Network, LLC, Houston
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Ap rekriteFaz 3
- JCCT- Juno Northwest Houston, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi lwen
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Ap rekriteFaz 3
- PrimeCare Medical Group, Houston
- JCCT- Juno NW Houston, Houston
- Biopharma Informatic_Houston, Houston
- ak 2 plis
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Ap rekriteFaz 3
- Texas Childrens Hospital, Houston
- UT Health Houston, Houston
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Ap rekriteFaz 3
- Research Site, Houston
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Ap rekrite
- Baylor College of Medicine, Houston
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
Ap rekriteVolontè an sante akeyiMande peman pou patisipan yo
- USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
CGM for Management of Type 2 Diabetes in Pregnancy
Ap rekrite
- University of Texas Health Science Center at Houston, Houston
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Ap rekriteFaz 2
- Synergy Group Medical, Houston
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Ap rekriteEtid obsèvasyon
- Baylor College of Medicine / Texas Children's, Houston
Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Lilli Health, Houston
RESET System Pivotal Trial (Rev F)
Ap rekrite
- Baylor College of Medicine, Houston
Etid Dyabèt Tip 2 nan lòt vil
- San Antonio, TX37 etid
- Orlando, FL24 etid
- Boston, MA20 etid
- Miami, FL19 etid
- Chicago, IL19 etid
- Dallas, TX19 etid
- Columbus, OH18 etid
- Las Vegas, NV18 etid
- Atlanta, GA17 etid
- San Diego, CA17 etid
- Los Angeles, CA16 etid
- New York City, NY16 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.